These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31510873)

  • 1. POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas.
    Calvete O; Garcia-Pavia P; Domínguez F; Mosteiro L; Pérez-Cabornero L; Cantalapiedra D; Zorio E; Ramón Y Cajal T; Crespo-Leiro MG; Teulé Á; Lázaro C; Morente MM; Urioste M; Benitez J
    J Am Heart Assoc; 2019 Sep; 8(18):e012875. PubMed ID: 31510873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.
    Calvete O; Martinez P; Garcia-Pavia P; Benitez-Buelga C; Paumard-Hernández B; Fernandez V; Dominguez F; Salas C; Romero-Laorden N; Garcia-Donas J; Carrillo J; Perona R; Triviño JC; Andrés R; Cano JM; Rivera B; Alonso-Pulpon L; Setien F; Esteller M; Rodriguez-Perales S; Bougeard G; Frebourg T; Urioste M; Blasco MA; Benítez J
    Nat Commun; 2015 Sep; 6():8383. PubMed ID: 26403419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The wide spectrum of POT1 gene variants correlates with multiple cancer types.
    Calvete O; Garcia-Pavia P; Domínguez F; Bougeard G; Kunze K; Braeuninger A; Teule A; Lasa A; Ramón Y Cajal T; Llort G; Fernández V; Lázaro C; Urioste M; Benitez J
    Eur J Hum Genet; 2017 Nov; 25(11):1278-1281. PubMed ID: 28853721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A POT1 mutation implicates defective telomere end fill-in and telomere truncations in Coats plus.
    Takai H; Jenkinson E; Kabir S; Babul-Hirji R; Najm-Tehrani N; Chitayat DA; Crow YJ; de Lange T
    Genes Dev; 2016 Apr; 30(7):812-26. PubMed ID: 27013236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mouse model for Li-Fraumeni-Like Syndrome with cardiac angiosarcomas associated to POT1 mutations.
    Martínez P; Sánchez-Vázquez R; Ferrara-Romeo I; Serrano R; Flores JM; Blasco MA
    PLoS Genet; 2022 Jun; 18(6):e1010260. PubMed ID: 35727838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere Replication Stress Induced by POT1 Inactivation Accelerates Tumorigenesis.
    Pinzaru AM; Hom RA; Beal A; Phillips AF; Ni E; Cardozo T; Nair N; Choi J; Wuttke DS; Sfeir A; Denchi EL
    Cell Rep; 2016 Jun; 15(10):2170-2184. PubMed ID: 27239034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis.
    Guo X; Deng Y; Lin Y; Cosme-Blanco W; Chan S; He H; Yuan G; Brown EJ; Chang S
    EMBO J; 2007 Nov; 26(22):4709-19. PubMed ID: 17948054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cells.
    Kunze K; Spieker T; Gamerdinger U; Nau K; Berger J; Dreyer T; Sindermann JR; Hoffmeier A; Gattenlöhner S; Bräuninger A
    Cancer Res; 2014 Nov; 74(21):6173-83. PubMed ID: 25252913
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Shen E; Xiu J; Lopez GY; Bentley R; Jalali A; Heimberger AB; Bainbridge MN; Bondy ML; Walsh KM
    J Med Genet; 2020 Oct; 57(10):664-670. PubMed ID: 31937561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.
    Denchi EL; de Lange T
    Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated POT1 mutations lead to telomere elongation without induction of a DNA damage response.
    Kim WT; Hennick K; Johnson J; Finnerty B; Choo S; Short SB; Drubin C; Forster R; McMaster ML; Hockemeyer D
    EMBO J; 2021 Jun; 40(12):e107346. PubMed ID: 33934394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RPA and POT1: friends or foes at telomeres?
    Flynn RL; Chang S; Zou L
    Cell Cycle; 2012 Feb; 11(4):652-7. PubMed ID: 22373525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pot1 and cell cycle progression cooperate in telomere length regulation.
    Churikov D; Price CM
    Nat Struct Mol Biol; 2008 Jan; 15(1):79-84. PubMed ID: 18066078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies.
    Zhrebker L; Cherni I; Gross LM; Hinshelwood MM; Reese M; Aldrich J; Guileyardo JM; Roberts WC; Craig D; Von Hoff DD; Mennel RG; Carpten JD
    BMC Cancer; 2017 Jan; 17(1):17. PubMed ID: 28056866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pot1b -/- tumors activate G-quadruplex-induced DNA damage to promote telomere hyper-elongation.
    Takasugi T; Gu P; Liang F; Staco I; Chang S
    Nucleic Acids Res; 2023 Sep; 51(17):9227-9247. PubMed ID: 37560909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood.
    Michler P; Schedel A; Witschas M; Friedrich UA; Wagener R; Mehtonen J; Brozou T; Menzel M; Walter C; Nabi D; Pearce G; Erlacher M; Göhring G; Dugas M; Heinäniemi M; Borkhardt A; Stölzel F; Hauer J; Auer F
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial quorum-sensing signal IQS induces host cell apoptosis by targeting POT1-p53 signalling pathway.
    Wang J; Wang C; Yu HB; Dela Ahator S; Wu X; Lv S; Zhang LH
    Cell Microbiol; 2019 Oct; 21(10):e13076. PubMed ID: 31254473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of telomeres 1 proteins POT1a and POT1b can repress ATR signaling by RPA exclusion, but binding to CST limits ATR repression by POT1b.
    Kratz K; de Lange T
    J Biol Chem; 2018 Sep; 293(37):14384-14392. PubMed ID: 30082315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA.
    Flynn RL; Centore RC; O'Sullivan RJ; Rai R; Tse A; Songyang Z; Chang S; Karlseder J; Zou L
    Nature; 2011 Mar; 471(7339):532-6. PubMed ID: 21399625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent Mutations of POT1 Distinguish Pulmonary Sarcomatoid Carcinoma From Other Lung Cancer Histologies.
    Shen E; Xiu J; Bentley R; López GY; Walsh KM
    Clin Lung Cancer; 2020 Nov; 21(6):e523-e527. PubMed ID: 32414627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.